NewsRoom Articles - Page 144 of 221

MondayOct 18, 2021 12:41 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Announce Beta Launch of Proprietary ‘MiBoKo’ Metabolic Health Program

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently announced the beta launch of MiBoKo, a combined application and non-invasive glucose sensor designed to help users track their metabolic scores US diabetes-related healthcare expenditures totalled $760 billion in 2019 alone, equating to an annual spend of over $9,000 per diabetic patient Nemaura Medical (NASDAQ: NMRD) is a cutting-edge medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company recently carried out the beta launch of MiBoKo, a new proprietary metabolic health program…

MondayOct 18, 2021 9:30 am

Study Finds That Substance-Use Disorders Heighten Risk of SARS-CoV-2 Breakthrough Infections

A recently conducted study has found that while the risk of SARS-CoV-2 breakthrough infection was low in vaccinated individuals with substance-use disorders, it was higher than the risk of vaccinated individuals who don’t suffer from substance use disorders. The research was conducted by researchers at the National Institute on Drug Abuse and was reported in “World Psychiatry.” Researchers from Case Western Reserve University also took part in the study. The researchers also discovered that adverse socioeconomic determinants of health, which are common in individuals suffering from substance use disorder and health conditions that occurred simultaneously, were primarily responsible for the…

FridayOct 15, 2021 9:36 am

Study Finds That Pandemic Caused Significant Increase in Mental Health Disorders

Prior to the COVID-19 pandemic, anxiety disorders and major depressive disorder were already huge contributors to the worldwide burden of disease, impacting millions of individuals across the globe. Now, a recent study has found that the coronavirus pandemic has caused a significant increase in major anxiety and depressive disorders globally. For this study, researchers identified more than 5,600 unique sources of data, almost 50 of which met the inclusion criteria. Most of the studies included were from North America and Western Europe, with a few from Central Europe, East Asia, the Asia-Pacific and Australasia also included in the analysis. The…

FridayOct 15, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Partners with University of Wisconsin Researchers for Clinical Pharmacology Studies Evaluating TRP-8803

Tryp Therapeutics has partnered with Dr. Paul Hutson and Dr. Christopher Nicholas, researchers at the University of Wisconsin-Madison The collaboration will focus on a clinical pharmacology studies to evaluate the safety and pharmacokinetics of TRP-8803, Tryp’s proprietary drug formulation The partnership is the latest in a series of collaborations as the company prepares for Phase 2b trials Tryp intends to use data from its Phase 2a clinical studies, expected to launch this year, coupled with preclinical data and clinical pharmacology data for TRP-8803, to support the use of the novel drug formulation in Phase 2b trials Tryp Therapeutics (CSE: TRYP)…

ThursdayOct 14, 2021 2:00 pm

Shining the Spotlight on Binge-Eating Disorder

Research shows that binge-eating disorder, which is more common than other eating disorders such as bulimia and anorexia, affects more women than men. Experts say that despite popular opinion that binge eating is a mood or phase, it is a serious issue that needs to be addressed. Regence BlueCross BlueShield’s executive medical director Dr. Amy Khan states that eating disorders often represent serious mental health conditions. Khan explains that eating disorders are serious ailments that can impact an individual’s social, emotional and physical functioning. This is in addition to affecting their cardiovascular health and causing gastrointestinal issues. The disorders are…

WednesdayOct 13, 2021 11:38 am

Second-, Third-Degree Relatives of Colon Cancer Patients at Risk of Developing the Ailment

A new study has discovered that having relatives who have colorectal cancer heightens an individual’s risk of developing this ailment. This study, which was conducted by researchers from the University of Utah and the University of Buffalo, was published in the “Cancer Epidemiology” journal. Physicians recommend that first-degree relatives of individuals diagnosed with early onset colorectal cancer begin screening before they reach 50 years of age. This is mainly because cases of early onset colorectal cancer have increased considerably in the last few decades. The research suggests that early screening may benefit second- and third-degree relatives as well. First-degree relatives…

TuesdayOct 12, 2021 1:31 pm

Research Finds That Costs Incurred by Neurology Patients Have Increased Significantly

New research has found that the costs for office visits and diagnostic tests for neurological conditions has increased significantly in the past decade or so. The research, which was reported in the American Academy of Neurology’s online issue of “Neurology,” discovered that individuals who registered for high-deductible health plans had higher chances of incurring higher costs than individuals on other plans. University of Michigan’s Chloe E. Hill, the author of the study, explained that this increase in costs could be harmful as it may prompt individuals to forgo diagnostic evaluation or leave those who complete their tests in financial strain…

TuesdayOct 12, 2021 1:24 pm

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) Among Leading Biotech Companies Innovating the Field of Early Cancer Screening and Detection

Blood and genomic testing are becoming preferable means of early cancer screening and detection Leaders innovating this niche of the medical industry include AnPac Bio, Grail, Thrive and Guardant AnPac Bio-Medical's testing features a database of more than 200,000 commercial and research multi-cancer test samples (probably the largest multi-cancer test data base) that detect up to 26 different types of cancer One of the few companies offering multi-cancer tests for risk assessment and actually contributing to the fight against cancer by having its high risk individuals (tested first by its tests and later) confirmed in the healthcare providers for cancer…

TuesdayOct 12, 2021 11:32 am

RYAH Group Inc. (CSE: RYAH) Positioned to Impact Palliative Care with AI-Powered Plant-Based Solutions

Palliative care focuses on providing end-of-life care for chronically ill patients Preliminary research suggests cannabis relieves pain, appetite loss, anxiety RYAH is the leader in volume-control technology for plant-based medicine RYAH’s ecosystem includes volume-control devices, medicine-carrying components, and AI-powered applications that capture and track data With a mission to advance remote-health solutions and analytics-based patient treatments across the world, RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, is positioned to address the urgent need for cannabis-based solutions in palliative care. Palliative care is an emerging healthcare field that focuses on providing solutions that alleviate the suffering…

MondayOct 11, 2021 9:30 am

Why Timely Data Analysis Is Vital in Health Care

We have seen a lot of businesses go digital in the last year. Researchers believe that artificial intelligence (“AI”) will be useful in various areas, including the health-care sector. Studies have shown that more than 50% of health-care facilities don’t have a strategy on how to carry out analytics and govern data. This is because the sector still lacks a structured database from which data can be read, interpreted and applied to treatments in the future. With the ongoing pandemic, new approaches to predictive analytics, data analysis and health care are needed more than ever. Why is data analysis important…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Nemaura Medical Inc. (NASDAQ: NMRD) Announce Beta Launch of Proprietary ‘MiBoKo’ Metabolic Health Program

Study Finds That Substance-Use Disorders Heighten Risk of SARS-CoV-2 Breakthrough Infections

Study Finds That Pandemic Caused Significant Increase in Mental Health Disorders

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Partners with University of Wisconsin Researchers for Clinical Pharmacology Studies Evaluating TRP-8803

Shining the Spotlight on Binge-Eating Disorder

Second-, Third-Degree Relatives of Colon Cancer Patients at Risk of Developing the Ailment

Research Finds That Costs Incurred by Neurology Patients Have Increased Significantly

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) Among Leading Biotech Companies Innovating the Field of Early Cancer Screening and Detection

RYAH Group Inc. (CSE: RYAH) Positioned to Impact Palliative Care with AI-Powered Plant-Based Solutions

Why Timely Data Analysis Is Vital in Health Care

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search